Experience in correcting eating disorders in the clinic of mental illness
| Autor: | Kateryna Dzivak, Ivan Romash, Iryna Romash, Oksana Kukhta, Hamna Ahmed |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Neurophysiology and neuropsychology
Marketing Pharmacology Organizational Behavior and Human Resource Management medicine.medical_specialty Metoclopramide QP351-495 Strategy and Management Pharmaceutical Science Mental illness medicine.disease Ondansetron mental illness BF1-990 Eating disorders Drug Discovery medicine Psychology Psychiatry |
| Zdroj: | Mental Health: Global Challenges Journal, Vol 4, Iss 2 (2021) |
| ISSN: | 2612-2138 |
| DOI: | 10.32437/mhgcj.v4i2.127 |
| Popis: | Introduction: Eating disorders - a class of psychogenic behavioral syndromes associated with eating disorders. The class of these disorders includes anorexia nervosa, bulimia nervosa, compulsive overeating, as well as several other disorders, which are included in the international classification, to section F 50-F 59. Purpose: The purpose of our study is to trace the dynamics of individual eating disorders in patients with various mental illnesses under the influence of corrective therapy. Methodology: Were examined 77 patients with various mental diseases who have had eating disorders. The first (I) group included 33 patients. They have added Metoclopramide at a dose of 20 mg/day to the main treatment. The second group (II) - 44 patients who received the drug Ondansetron at a dose of 4 mg/day, respectively. The condition of all patients was assessed according to the following scales: Eating Attitudes Test (EAT-26), 36-Item Short-Form Health Status (SF-36). Body mass index (BMI) was calculated to study the dynamics of weight. All examinations of patients were performed at the beginning and after 14 days of treatment. Results: According to the EAT-26 scale the average score in the I group was 29 ± 2.8 points, and in the II - 30.1 ± 2.4, respectively. According to the SF-36 questionnaire, the average total score in the I group was - 69.5 ± 1.8 before treatment, 79.5 ± 1.6 - after treatment improved by 12.5% (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|